Fig. 3From: Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectivesTreatment of primary GN with nanomaterials. In the treatment of primary GN, a nanodrug delivery system can deliver various drugs and nucleic acids to mesangial cells, endothelial cells and the mesangium. Nanoparticles can also play a therapeutic role by blocking ion channels. GN glomerulonephritis, PCL-PCL polyethylene, glycol-polycaprolactone, DXM dexamethasone, EGCG epigallocatechi gallate, TW tripterygium wilfordii; EPO erythropoietinBack to article page